IBD Evidence

Dietary approach

Exclusive enteral nutrition for IBD: what the evidence shows

A period of formula-only feeding, typically six to eight weeks, with no other food.

Updated 2 min read 10 citations

Compound light microscope with objective turret and stage, standing on a bench
Ajay Kumar Chaurasiya · CC BY-SA 4.0 · Wikimedia Commons

What the evidence actually supports

First-line induction therapy for paediatric Crohn's disease in European guidelines, with mucosal healing rates comparable to corticosteroids and without the steroid side-effect burden. [1]

Adherence is genuinely hard and relapse on reintroduction is common. Evidence in adults is weaker than in children.

Evidence strength across the dietary approaches profiled Of the 8 dietary approaches profiled for inflammatory bowel disease, this shows how many sit at each level of evidence, with this approach graded established. Promising5 approachesEstablished1 approachesLimited1 approachesPopular but weak1 approaches
Exclusive enteral nutrition is graded established. The grades are deliberately coarse: the distance between a guideline-endorsed induction therapy and a diet with no controlled trials is the thing worth seeing, and a finer scale would imply a precision the literature does not support. Grades assigned from trial design and guideline status; see the method note.

Where it fits

This is among the better-supported dietary interventions in inflammatory bowel disease and appears in clinical guidance. That does not make it easy, and adherence is usually the limiting factor rather than efficacy.

How we grade these

Four coarse grades rather than a score. "Established" means randomised trials or guideline endorsement. "Promising" means a consistent signal from trials that are small or short. "Limited" means mechanistic or observational evidence only. "Popular but weak" means widely used and poorly supported — a category that exists because pretending those approaches are not out there helps nobody.

Compound microscope set up on a university laboratory bench
syed sajidul islam · CC BY 4.0 · Wikimedia Commons

Other approaches

Does Exclusive enteral nutrition work for IBD?
First-line induction therapy for paediatric Crohn's disease in European guidelines, with mucosal healing rates comparable to corticosteroids and without the steroid side-effect burden. Adherence is genuinely hard and relapse on reintroduction is common. Evidence in adults is weaker than in children.
Can diet replace medication in IBD?
Generally no. Exclusive enteral nutrition is the notable exception for inducing remission in paediatric Crohn's disease. Everything else is adjunctive, and inflammation still needs monitoring.
Is a restrictive diet harmful?
It can be. Prolonged restriction reduces microbial diversity and risks nutritional gaps, which is why protocols with a reintroduction phase treat that phase as part of the intervention rather than optional.
Should I try this without telling my doctor?
No — particularly not if it might mask symptoms while inflammation continues. Symptom relief and mucosal healing are different endpoints and can diverge.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Mediterranean diet in treatment of inflammatory bowel disease: A systematic review and meta-analysis Singh A, Rana U, Chandnani S, et al. · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026 · Meta-analysis DOIPubMed 41803562
  2. Study Design Complexity and Participant Completion in Dietary Trials for Inflammatory Bowel Disease: A Systematic Review and Metaresearch Study Gregersen L, Moos C, Hikmat Z, et al. · Advances in nutrition (Bethesda, Md.) · 2026 · Systematic review DOIPubMed 41825595Full text
  3. Evaluating the causal connections between sleep duration and disease prevalence: A comprehensive systematic review and meta-analysis of Mendelian randomization studies Wang Z, Yao L, Tu M · Medicine · 2026 · Meta-analysis DOIPubMed 41517697Full text
  4. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease Felipez LM, Ali S, de Zoeten EF, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40692184Full text
  5. Pre-Illness Index-Based Dietary Patterns and Inflammatory Bowel Disease Risk: A Systematic Review and Meta-Analysis Meng F, Zhang T, Meng X, et al. · Nutrition reviews · 2025 · Meta-analysis DOIPubMed 40700526
  6. Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review Gleave A, Shah A, Tahir U, et al. · The American journal of gastroenterology · 2025 · Systematic review DOIPubMed 39056556
  7. Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders-A Systematic Review of Randomized Controlled Trials Kuźmin L, Kubiak K, Lange E · Nutrients · 2025 · Systematic review DOIPubMed 40573159Full text
  8. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  9. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review Hashash JG, Elkins J, Lewis JD, et al. · Gastroenterology · 2024 · Clinical guideline DOIPubMed 38276922
  10. Is There Evidence of Crohn's Disease Exclusion Diet (CDED) in Remission of Active Disease in Children and Adults? A Systematic Review Correia I, Oliveira PA, Antunes ML, et al. · Nutrients · 2024 · Systematic review DOIPubMed 38613020Full text